Trial result ·
Acetic acid chromoendoscopy for detection of neoplastic Barrett's oesophagus: stepped wedge cluster randomised controlled trial (ACID-trial).
Written based on 1 research study on PubMed, searched on 3 Nov 2026.
What was studied
This was a stepped wedge cluster randomised trial in 18 Dutch community hospitals. It tested acetic acid chromoendoscopy (AAC) during checks of Barrett's oesophagus. The goal was to see if AAC finds more dysplasia and oesophageal cancer. Hospitals shifted at random from checks without AAC to checks with AAC. Endoscopists were trained first. Patients with known or treated dysplasia were left out.
What they found
2267 people took part. 1438 had checks without AAC and 829 had AAC. AAC was used in 679 of the 829. Neoplasia was found in 163 people. Of these, 111 had low grade dysplasia and 30 had high grade. 22 had oesophageal cancer. AAC did not raise the neoplasia detection rate. The odds ratio was 0.97. Suspected lesions were found more often with AAC. But targeted biopsies did not find more neoplasia.
What it means for patients
The authors conclude that AAC did not improve detection of neoplasia. This applies to people with Barrett's oesophagus under surveillance in routine care.
Why it is not certain yet
The trial was open-label. Hospitals were randomised, not people. AAC was used in 679 of the 829 people assigned to it. The abstract does not say how long patients were followed.
Source
Acetic acid chromoendoscopy for detection of neoplastic Barrett's oesophagus: stepped wedge cluster randomised controlled trial (ACID-trial).
PubMed · PMID 42907095We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Barrett's oesophagus publications